SynAct Pharma AB's market cap is currently €113.94M. The company's EPS TTM is €-0.051398834000000004; its P/E ratio is ―; SynAct Pharma AB is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
